Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Masterson

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Urologic Oncology|February 1, 2020
Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?Adam C Calaway, Richard S Foster, Yan Tong, et al.
BJU International|March 16, 2017
Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term updateJane S Cho, Hristos Z Kaimakliotis, Clint Cary, et al.
Journal of Endourology|April 9, 2008
Risk stratification for positive lymph nodes in prostate cancerJoseph A Pettus, Timothy A Masterson, E Jason Abel, et al.
BJU International|February 19, 2008
Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile functionTimothy A Masterson, Angel M Serio, John P Mulhall, et al.
Urology|February 27, 2019
Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal TumorsAdam C Calaway, Isamu Tachibana, Timothy A Masterson, et al.
Urologic Oncology|October 10, 2024
Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancerRaymond A Smith, Jacob D McFadden, Andres Fajardo, et al.
BJU International|March 8, 2012
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumourTimothy A Masterson, Brett S Carver, E Jason Abel, et al.
Clinical Genitourinary Cancer|March 12, 2026
Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLNDSean Q Kern, Naveen Krishnan, Nabil Adra, et al.
Journal of Endourology|September 16, 2014
Can radiologists and urologists reliably determine renal mass histology using standard preoperative computed tomography imaging?M Francesca Monn, Paul T Gellhaus, Aashish A Patel, et al.
The Journal of Urology|September 26, 2014
The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumorsK Clint Cary, Jose A Pedrosa, Hristos Z Kaimakliotis, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Urologic Oncology|February 1, 2020
Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?Adam C Calaway, Richard S Foster, Yan Tong, et al.
BJU International|March 16, 2017
Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term updateJane S Cho, Hristos Z Kaimakliotis, Clint Cary, et al.
Journal of Endourology|April 9, 2008
Risk stratification for positive lymph nodes in prostate cancerJoseph A Pettus, Timothy A Masterson, E Jason Abel, et al.
BJU International|February 19, 2008
Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile functionTimothy A Masterson, Angel M Serio, John P Mulhall, et al.
Urology|February 27, 2019
Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal TumorsAdam C Calaway, Isamu Tachibana, Timothy A Masterson, et al.
Urologic Oncology|October 10, 2024
Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancerRaymond A Smith, Jacob D McFadden, Andres Fajardo, et al.
BJU International|March 8, 2012
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumourTimothy A Masterson, Brett S Carver, E Jason Abel, et al.
Clinical Genitourinary Cancer|March 12, 2026
Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLNDSean Q Kern, Naveen Krishnan, Nabil Adra, et al.
Journal of Endourology|September 16, 2014
Can radiologists and urologists reliably determine renal mass histology using standard preoperative computed tomography imaging?M Francesca Monn, Paul T Gellhaus, Aashish A Patel, et al.
The Journal of Urology|September 26, 2014
The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumorsK Clint Cary, Jose A Pedrosa, Hristos Z Kaimakliotis, et al.
Pageof 12